AG真人官方

Astronics Corporation Reports Record Aerospace Segment Sales in 2025 Second Quarter

• Second quarter sales increased 3.3% to $204.7听million driven by Aerospace growth of 9.4% to a record $193.6听尘颈濒濒颈辞苍
• Second quarter net income was $1.3听million, or $0.04 per diluted share; adjusted EBITDA¹ was $25.4听尘颈濒濒颈辞苍, or 12.4% of sales
• Aerospace operating margin was 9.3% including investments in simplification initiatives and legal fee reimbursement; adjusted operating margin¹ was 16.3%
• Test Systems restructuring cost savings masked by $6.9听million impact to profitability from estimated cost to complete adjustments
• Solid quarterly bookings of $177.0听million and backlog of $645.4听尘颈濒濒颈辞苍
• Raised lower end of revenue guidance to range of $840听尘颈濒濒颈辞苍 to $860听尘颈濒濒颈辞苍 for 2025

EAST AURORA, N.Y.--(BUSINESS WIRE)-- (Nasdaq: ATRO) (鈥淎stronics鈥� or the 鈥淐ompany鈥�), a leading supplier of advanced technologies and products to the global aerospace, defense, and other mission critical industries, today reported financial results for the three and six months ended June 28, 2025.

Peter J. Gundermann, Chairman, President and Chief Executive Officer, commented, 鈥淲e had a very solid second quarter and demonstrated continued progress as revenue stabilizes above $200 million per quarter. We also took some actions that will improve our future earnings power. After a company-wide review of our product portfolio, we took the action to step away from a couple of product lines that have proven to be low margin and low growth. We also took a meaningful increase in our estimate to complete for some projects in our Test business, which masked the progress we have made restructuring that business in recent quarters. These actions will allow us to simplify our business and focus on efforts that promise the greatest returns. Combined with the supportive market conditions we are experiencing, we believe we are well positioned for the future as we look to finish strong in 2025 and beyond.鈥�

Second Quarter Results

Second Quarter 2025 Results (compared with the prior-year period, unless noted otherwise)

Growth in sales was driven by the Aerospace segment鈥檚 continued strength in demand primarily from the Commercial Transport market. Aerospace sales increased $16.7 million, or 9.4%, which more than offset a $10.1 million decline in Test Systems sales. Consolidated sales were negatively impacted by $6.4 million due to revisions of estimated costs to complete certain long-term mass transit contracts in the Test Systems segment.

Gross profit decreased $2.7 million to $52.8 million, or 25.8% of sales. As noted above, a revision of estimated costs to complete certain long-term mass transit contracts in the Test Systems segment resulted in a $6.9 million impact on gross profit. Additionally, simplification initiatives in the Aerospace segment, including costs related to footprint rationalization and product portfolio shaping activities, resulted in $5.8 million in charges within cost of products sold during the quarter. Adjusted gross profit² for the 2025 second quarter was $59.7 million, or 29.2% of sales, an improvement over 28.0% in the comparator quarter, primarily attributable to higher volume and improving productivity.

In the second quarter of 2025, the $2.7 million increase in selling, general and administrative expenses (鈥淪G&A鈥�) included a $3.5 million legal fee reimbursement charge relating to the patent infringement dispute in the UK, partially offset by a $1.7 million decrease in litigation-related legal expenses. R&D was down $2.6 million reflecting the timing of projects.

Consolidated operating income decreased $2.8 million to $4.8 million, or 2.3% of sales. The impact of the revision of estimated costs on operating income was $6.9 million. Adjusted operating income² for the 2025 second quarter was $18.3 million, or 8.9% of sales, compared with $12.6 million, or 6.4% of sales, in the 2024 second quarter, which represents margin gain on increased volume and improved productivity in the Aerospace segment, coupled with realized savings from the recent Test Systems cost rationalization activities. The revision of estimated costs were not included as an add back for adjusted operating income².

As a result of the refinancing in December 2024, interest expense was down $2.8 million, or 47.1%. Tax expense in the quarter was $0.5 million compared with a tax benefit of $0.3 million in the prior-year period.

Consolidated net income of $1.3 million, or $0.04 per diluted share, compares with net income of $1.5 million, or $0.04 per diluted share, in the prior-year period. Adjusted net income² for the 2025 second quarter increased $6.5 million to $13.7 million, or $0.38 per diluted share, resulting from stronger profitability and lower interest expense.

Consolidated adjusted EBITDA² increased 25.5% to $25.4 million, and was 12.4% of consolidated sales.

Bookings of $177.0 million in the quarter resulted in a book-to-bill ratio of 0.86:1. For the trailing twelve months, bookings totaled $841.8 million and the book-to-bill ratio was 1.02:1. Backlog at the end of the quarter was $645.4 million.

Aerospace Segment Review (refer to sales by market and segment data in accompanying tables)

Aerospace Second Quarter 2025 Results (compared with the prior-year period, unless noted otherwise)

Record Aerospace segment sales of $193.6 million increased $16.7 million, or 9.4%. Sales in the Commercial Transport market increased $17.2 million, or 13.4%. Growth was primarily related to increased demand by airlines for cabin power and inflight entertainment & connectivity (鈥淚FEC鈥�) products. Military Aircraft sales increased $2.7 million, or 10.7%, to $27.4 million, driven by increased demand for lighting and safety products. General Aviation sales decreased $0.6 million, or 3.4%, to $18.4 million due to lower airframe power sales. Other sales decreased $2.5 million as the Company is winding down its non-core contract manufacturing arrangements.

Aerospace segment operating profit of $18.0 million, or 9.3% of sales, decreased over the prior-year period as a result of the previously discussed $6.2 million charge related to simplification initiatives, a $3.5 million legal fee reimbursement charge related to the UK patent dispute, and a $1.0 million warranty expense true-up related to a new product launch that requires a field modification. These were partially offset by a $1.5 million decrease in litigation-related expenses. Adjusted Aerospace operating profit² was $31.5 million, or 16.3% of sales, up 300 basis points from the comparator quarter, reflecting the leverage gained on higher volume, pricing initiatives, and improving production efficiencies.

Aerospace bookings were $150.6 million for a book-to-bill ratio of 0.78:1. Backlog for the Aerospace segment was $570.9 million at quarter end.

Mr. Gundermann commented, 鈥淓xcluding the unusual items in the quarter, our Aerospace business had a strong second quarter. Sales hit a new record and adjusted operating margin² showed consistent improvement. The reserves we took are the result of a determined focus on those business initiatives that are most important to our future, which we believe continues to look very positive.鈥�

Test Systems Segment Review (refer to sales by market and segment data in accompanying tables)

Test Systems Second Quarter 2025 Results (compared with the prior-year period, unless noted otherwise)

Test Systems segment sales were $11.1 million, down $10.1 million from the comparator quarter in 2024. Segment sales were negatively impacted by $6.4 million due to revisions of estimated costs to complete certain long-term mass transit Test contracts. The revisions resulted in reduced revenue recognized in the respective periods due to lower estimates of the percentage of work completed on the programs.

Test Systems segment operating loss was $6.7 million, compared with an operating loss of $5.3 million in the second quarter of 2024. The revisions to the estimated costs to complete had a $6.9 million detrimental impact to operating income and masked the savings realized from recent restructuring activities. While Test Systems continues to be negatively affected by mix and under absorption of fixed costs at current volume levels, the second half of 2025 is expected to be improved for revenue and operating income despite a six-to-eight-week delay in a U.S. Army radio test program.

Bookings for the Test Systems segment in the quarter were $26.4 million. The book-to-bill ratio was 2.39:1 for the quarter. Backlog for the Test Systems segment was $74.5 million at quarter end.

Mr. Gundermann commented, 鈥淲e initiated a deep dive into some of our major long term Test programs in the second quarter and concluded the EAC adjustment was appropriate at this time. The deep dive will continue into the third quarter but we expect we have adequately captured the situation as it stands today. The EAC adjustment unfortunately masks the benefit of certain restructuring steps we have taken in recent quarters. With the EAC adjustment behind us, we believe the business is positioned for a stronger close to 2025 with accelerating momentum as we look forward to 2026.鈥�

Liquidity and Financing

Cash used by operations in the second quarter of 2025 was $7.6 million after $21.6 million in payments related to the UK patent dispute and $12.0 million in net income tax payments.

Capital expenditures in the quarter were $4.6 million. Long-term debt, net of cash, decreased $4.4 million to $145.8 million at quarter end compared with $150.2 million at the end of the year. The Company had available liquidity of $191.3 million at the end of the second quarter.

2025 Outlook

Astronics is raising the lower end of its 2025 revenue guidance to approximately $840 million to $860 million, up from previous guidance of $820 million to $860 million. The midpoint of the revised range would be a 6.9% increase over 2024 sales.

The Company is monitoring the evolving tariff situation closely. Astronics generates approximately 90% of its revenue from operations in the United States, though it has an international supply chain and a global list of customers. Based on the tariff rates in effect today, Astronics believes the potential incremental impact to annual costs of materials related to direct and known indirect effects is in the range of $15 million to $20 million before mitigation. The Company believes that certain actions including pass-through pricing, supply chain restructuring, duty drawbacks, the implementation of free trade zones, and other operational adjustments will significantly reduce the anticipated impacts of tariffs over time. The Company expects that tariff rates will remain in flux in the near future and will refine its strategy as the situation becomes more stable.

Backlog at the end of the second quarter was $645.4 million, of which approximately 75% is expected to be recognized as revenue over the next twelve months. Planned capital expenditures in 2025 are expected to be in the range of $40 million to $50 million.

Mr. Gundermann commented, 鈥淭he first half of 2025 was very positive for our Company and we believe activity will accelerate as we move into the second half of the year. The production phase of our Radio Test Program for the U.S. Army may slide into early 2026, but our aerospace business is accelerating more than enough to compensate. We are raising our 2025 revenue guidance accordingly by $10 million at the mid-point. Our business continues to strengthen, including the efficiency of our work force and the dependability of our supply chain, and we have a near-record backlog. The signs are positive as we work toward the end of the year.鈥�

Second Quarter 2025 Webcast and Conference Call

The Company will host a teleconference today at 4:45 p.m. ET. During the teleconference, management will review the financial and operating results for the period and discuss Astronics鈥� corporate strategy and outlook. A question-and-answer session will follow.

The Astronics conference call can be accessed by calling (201) 493-6784. The listen-only audio webcast can be monitored at investors.astronics.com. To listen to the archived call, dial (412) 317-6671 and enter replay pin number 13754268. The telephonic replay will be available from 8:00 p.m. on the day of the call through Wednesday, August 20, 2025. The webcast replay can be accessed via the investor relations section of the Company鈥檚 website where a transcript will also be posted once available.

About Astronics Corporation

Astronics Corporation (Nasdaq: ATRO) serves the world鈥檚 aerospace, defense, and other mission-critical industries with proven innovative technology solutions. Astronics works side-by-side with customers, integrating its array of power, connectivity, lighting, structures, interiors, and test technologies to solve complex challenges. For over 50 years, Astronics has delivered creative, customer-focused solutions with exceptional responsiveness. Today, global airframe manufacturers, airlines, military branches, completion centers, and Fortune 500 companies rely on the collaborative spirit and innovation of Astronics. The Company鈥檚 strategy is to increase its value by developing technologies and capabilities that provide innovative solutions to its targeted markets.

Safe Harbor Statement

This news release contains forward-looking statements as defined by the Securities Exchange Act of 1934. One can identify these forward-looking statements by the use of the words 鈥渆xpect,鈥� 鈥渁nticipate,鈥� 鈥減lan,鈥� 鈥渕ay,鈥� 鈥渨ill,鈥� 鈥渆stimate,鈥� 鈥渇eeling鈥� or other similar expressions and include all statements with regard to the Company鈥檚 2025 outlook, the amount of capital expenditures for 2025, the amount of the impact of tariffs on costs for materials to the Company and level of mitigation potential with respect thereto, the amount of backlog to be recognized as revenue over the next twelve months, costs or outcomes of any business reviews or rationalization efforts, and statements regarding the strategy of the Company and its outlook. Forward-looking statements also include all statements related to achieving any revenue or profitability expectations, expectations of continued growth, the level of liquidity, the level of cash generation, the level of demand by customers and markets and the amount of expected capital expenditures. Because such statements apply to future events, they are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated by the statements. Important factors that could cause actual results to differ materially from what may be stated here include the trend in growth with passenger power and connectivity on airplanes, the state of the aerospace and defense industries, the market acceptance of newly developed products, internal production capabilities, the timing of orders received, the status of customer certification processes and delivery schedules, the demand for and market acceptance of new or existing aircraft which contain the Company鈥檚 products, the impact of regulatory activity and public scrutiny on production rates of a major U.S. aircraft manufacturer, the need for new and advanced test and simulation equipment, customer preferences and relationships, the effectiveness of the Company鈥檚 supply chain, and other factors which are described in filings by Astronics with the Securities and Exchange Commission. Except as required by applicable law, the Company assumes no obligation to update forward-looking information in this news release whether to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial conditions or prospects, or otherwise.

Use of Non-GAAP Financial Metrics and Additional Financial Information

In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, Astronics provides Adjusted Non-GAAP information as additional information for its operating results. References to Adjusted Non-GAAP information are to non-GAAP financial measures. These measures are not required by, in accordance with, or an alternative for, GAAP and may be different from non-GAAP financial measures used by other companies. Astronics management uses these measures for reviewing the financial results of Astronics for budget planning purposes and for making operational and financial decisions. Management believes that providing these non-GAAP financial measures to investors, as a supplement to GAAP financial measures, help investors evaluate Astronics core operating and financial performance and business trends consistent with how management evaluates such performance and trends.

FINANCIAL TABLES FOLLOW

Adjusted EBITDA is defined as net income before interest expense, income taxes, depreciation, amortization, and other adjustments. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by sales. Adjusted EBITDA and Adjusted EBITDA Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted EBITDA and Adjusted EBITDA Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted EBITDA and Adjusted EBITDA Margin, are important for investors and other readers of the Company鈥檚 financial statements.

Adjusted Gross Profit is defined as gross profit as reported, adjusted for certain items. Adjusted Gross Profit Margin is defined as Adjusted Gross Profit divided by sales. Adjusted Gross Profit and Adjusted Gross Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted Gross Profit and Adjusted Gross Profit Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Gross Profit and Adjusted Gross Profit Margin, are important for investors and other readers of the Company鈥檚 financial statements and assists in understanding the comparison of the current quarter鈥檚 and current year鈥檚 gross profit and gross profit margin to the historical periods鈥� gross profit, as well as facilitates a more meaningful comparison of the Company鈥檚 gross profit and gross profit margin to that of other companies.

Adjusted Operating Income is defined as income from operations as reported, adjusted for certain items. Adjusted Operating Margin is defined as Adjusted Operating Income divided by sales. Adjusted Operating Income and Adjusted Operating Margin are not measures determined in accordance with GAAP and may not be comparable with Adjusted Operating Income and Adjusted Operating Margin as used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Operating Income and Adjusted Operating Margin, are important for investors and other readers of the Company鈥檚 financial statements and assists in understanding the comparison of the current periods鈥� income from operations to the historical periods鈥� income from operations and operating margin, as well as facilitates a more meaningful comparison of the Company鈥檚 income from operations and operating margin to that of other companies.

Adjusted Net Income and Adjusted Diluted EPS are defined as net income and diluted EPS as reported, adjusted for certain items, including amortization of intangibles, and also adjusted for a normalized tax rate. Adjusted Net Income and Adjusted Diluted EPS are not measures determined in accordance with GAAP and may not be comparable with the measures used by other companies. Nevertheless, the Company believes that providing non-GAAP financial measures, such as Adjusted Net Income and Adjusted Diluted EPS, are important for investors and other readers of the Company鈥檚 financial statements and assists in understanding the comparison of the current periods鈥� net income and diluted EPS to the historical periods鈥� net income and diluted EPS, as well as facilitates a more meaningful comparison of the Company鈥檚 net income and diluted EPS to that of other companies. The Company believes that presenting Adjusted Diluted EPS provides a better understanding of its earnings power inclusive of adjusting for the non-cash amortization of intangible assets, reflecting the Company鈥檚 strategy to grow through acquisitions as well as organically.